ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 094,97
-0,09%
Dow Jones
39 069,59
0,01%
DAX
18 693,37
0,04%
Brent Oil
81,965
0,00%
Bitcoin
68 892,73
-0,54%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Cytek Biosciences Inc (CTKB)

  7. Cytek Biosciences Inc (CTKB) Actualités

CTKB

Cytek Biosciences (CTKB)

Cytek Biosciences Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:CTKB
DateHeureSourceTitreSymboleSociété
23/05/202400h41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTKBCytek Biosciences Inc
20/05/202423h30GlobeNewswire Inc.Cytek® Biosciences Adds Ability to Detect Subcellular Particles to Its Industry-Leading Cell Analysis SystemsNASDAQ:CTKBCytek Biosciences Inc
08/05/202422h35Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CTKBCytek Biosciences Inc
08/05/202422h20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CTKBCytek Biosciences Inc
08/05/202422h05GlobeNewswire Inc.Cytek Biosciences Reports First Quarter 2024 Financial ResultsNASDAQ:CTKBCytek Biosciences Inc
30/04/202423h30GlobeNewswire Inc.Cytek® Biosciences to Spotlight Cell Analysis Solutions at Upcoming Conferences in the United States and EuropeNASDAQ:CTKBCytek Biosciences Inc
29/04/202415h00GlobeNewswire Inc.Cytek Biosciences to Report First Quarter 2024 Financial Results on May 8, 2024NASDAQ:CTKBCytek Biosciences Inc
19/03/202413h00GlobeNewswire Inc.Cytek® Biosciences Names William McCombe Chief Financial OfficerNASDAQ:CTKBCytek Biosciences Inc
07/03/202423h30GlobeNewswire Inc.Cytek® Biosciences Opens New Facility to Address Increasing Global Demand for Cutting-Edge Cell Analysis SolutionsNASDAQ:CTKBCytek Biosciences Inc
28/02/202423h05GlobeNewswire Inc.Cytek Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 OutlookNASDAQ:CTKBCytek Biosciences Inc
14/02/202422h07Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CTKBCytek Biosciences Inc
07/02/202422h10GlobeNewswire Inc.Cytek Biosciences to Participate in Upcoming Investor ConferencesNASDAQ:CTKBCytek Biosciences Inc
07/02/202422h05GlobeNewswire Inc.Cytek Biosciences to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024NASDAQ:CTKBCytek Biosciences Inc
17/01/202423h30GlobeNewswire Inc.Cytek® Biosciences Signs Agreement with CRG and UPF to Accelerate Scientific DiscoveriesNASDAQ:CTKBCytek Biosciences Inc
08/01/202415h00GlobeNewswire Inc.Cytek Biosciences Announces Preliminary Full Year 2023 Revenue ResultsNASDAQ:CTKBCytek Biosciences Inc
28/12/202322h05GlobeNewswire Inc.Cytek Biosciences to present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:CTKBCytek Biosciences Inc
21/12/202315h00GlobeNewswire Inc.Cytek® Biosciences Introduces the Cytek Orion™ Reagent Cocktail Preparation System, the First-of-its-Kind Automated Cocktail Preparation Instrument for Flow CytometryNASDAQ:CTKBCytek Biosciences Inc
19/12/202322h28Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CTKBCytek Biosciences Inc
14/11/202322h05GlobeNewswire Inc.Cytek Biosciences to participate in the Piper Sandler 35th Annual Healthcare ConferenceNASDAQ:CTKBCytek Biosciences Inc
13/11/202322h02Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:CTKBCytek Biosciences Inc
08/11/202315h00GlobeNewswire Inc.Cytek® Aurora™ CS System Wins BioTech Breakthrough Award for ‘Cell Sorting Product of the Year’NASDAQ:CTKBCytek Biosciences Inc
07/11/202322h05GlobeNewswire Inc.Cytek Biosciences Reports Third Quarter 2023 Financial ResultsNASDAQ:CTKBCytek Biosciences Inc
19/10/202322h05GlobeNewswire Inc.Cytek Biosciences to Report Third Quarter 2023 Financial Results on November 7, 2023NASDAQ:CTKBCytek Biosciences Inc
27/09/202315h00GlobeNewswire Inc.Cytek® Biosciences Achieves ISO 13485 Certification at HeadquartersNASDAQ:CTKBCytek Biosciences Inc
20/09/202322h15GlobeNewswire Inc.Cytek Biosciences to Participate in the 2023 Cantor Fitzgerald Global Healthcare ConferenceNASDAQ:CTKBCytek Biosciences Inc
20/09/202315h00GlobeNewswire Inc.Cytek® Biosciences Cell Analysis Solutions Take Center Stage at Upcoming Clinical Conferences in the US and EuropeNASDAQ:CTKBCytek Biosciences Inc
14/09/202315h00GlobeNewswire Inc.Cytek® Biosciences Launches Educational Roadshow Focused on Spectral Flow CytometryNASDAQ:CTKBCytek Biosciences Inc
06/09/202322h10GlobeNewswire Inc.Cytek Biosciences to participate in the Morgan Stanley 21st Annual Global Healthcare ConferenceNASDAQ:CTKBCytek Biosciences Inc
30/08/202300h01Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CTKBCytek Biosciences Inc
28/08/202311h30GlobeNewswire Inc.Cytek Biosciences Appoints Dr. Philippe Busque Senior Vice President of Global Sales & ServicesNASDAQ:CTKBCytek Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:CTKB

Dernières Valeurs Consultées

TG
21L
Alphamin Resources
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés